Company intelligence / Profile preview

Brightlobe

St Albans, Hertfordshire, Englandbrightlobe.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Brightlobe has completed Phase 1 of a clinical trial with over 300 participants for its game-based early detection system targeting autism and ADHD in children. Phase 2 is currently underway. The company’s technology integrates with major gaming engines to enable healthcare-focused applications, with patents pending and support from international awards and grants.

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapy (game-based digital tool)
Industry: Digital Health Medical Devices

Partnerships

UK healthcare partners; specific names not disclosed as of June 2025

Beyond the preview

Go deeper on Brightlobe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brightlobe.

Explore the full profile